Showing results (941-950 of 1,698) with videos related to

Sort By:
Pageof 170
Toxins|August 24, 2018
Phoneutria nigriventer Spider Toxin PnTx2-1 (δ-Ctenitoxin-Pn1a) Is a Modulator of Sodium Channel GatingSteve Peigneur, Ana Luiza B Paiva, Marta N Cordeiro, et al.
EJNMMI Research|July 10, 2020
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptakeThomas Blom, Rutger Meinsma, Marja Rutgers, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 1981
Evaluation of a human pancreas-specific antigen by enzyme-linked immunosorbent assayR Loor, M Kuriyama, M L Manzo, et al.
European Journal of Gastroenterology & Hepatology|April 2, 1999
Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?A W van Milligen de Wit, H Kuiper, L Camoglio, et al.
The Journal of Infectious Diseases|May 1, 1996
The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseasesJ F Weel, R W van der Hulst, Y Gerrits, et al.
Pediatric Blood & Cancer|August 1, 2020
Use of quality indicators in neuroblastoma treatment: A feasibility assessmentSuzan Dijkstra, Kathelijne C J M Kraal, Godelieve A M Tytgat, et al.
Gastrointestinal Endoscopy|January 12, 2001
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomyJ J Bergman, A M van Berkel, M J Bruno, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2001
Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppressionE M Vreeburg, M Levi, E A Rauws, et al.
The Journal of Family Practice|April 30, 2002
How do primary care physicians use long-term acid suppressant drugs? A population-based analysis of Dutch general practicesG J B Hurenkamp, H G L M Grundmeyer, P J E Bindels, et al.
Annals of the Rheumatic Diseases|February 1, 1978
Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel diseaseB J Dekker-Saeys, S G Meuwissen, E M Van Den Berg-Loonen, et al.
Pageof 170